Woodline Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Woodline Partners’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-54,545	Closed	-$17.8M	–	707
2024 Q1	$17.8M	Buy	+54,545	New	+$13.4M	0.16%	188
2022 Q2	–	Sell	-7,815	Closed	-$1.62M	–	915
2022 Q1	$1.62M	Buy	+7,815	New	+$1.29M	0.03%	409

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Woodline Partners's SWAV Position: Q2 2024 in Review

Woodline Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 54,545 shares — an estimated $17.8M sold.

Woodline Partners first reported a position in SWAV in Q1 2022 and held it in 2 quarters. The position peaked at $17.8M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Woodline Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Woodline Partners sold 54,545 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $17.8M.
Woodline Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Woodline Partners's Shockwave Medical, Inc. Common Stock position peaked at $17.8M in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.